Related references
Note: Only part of the references are listed.Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
Lukasz Matusiak et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa
A. L. Lima et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Adalimumab: A Review in Hidradenitis Suppurativa
Esther S. Kim et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2016)
Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
J. L. Blok et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Inflammatory Mechanisms in Hidradenitis Suppurativa
G. Kelly et al.
DERMATOLOGIC CLINICS (2016)
IL-6 pathway in the liver: From physiopathology to therapy
Dirk Schmidt-Arras et al.
JOURNAL OF HEPATOLOGY (2016)
Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Evaluation clinique de la severite de l'hidradenite suppuree - maladie de Verneuil
J. Revuz
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2015)
Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients
Peter Theut Riis et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2015)
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
Alex Anstey
BRITISH JOURNAL OF DERMATOLOGY (2015)
Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)
Schapoor Hessam et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Treatment of hidradenitis suppurativa with biologic medications
Robert A. Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Pathophysiology of hidradenitis suppurativa: An update
Errol Prens et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes
Hessel H. van der Zee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
An Update on Hidradenitis Suppurativa (Part I): Epidemiology, Clinical Aspects, and Definition of Disease Severity
A. Martorell et al.
ACTAS DERMO-SIFILIOGRAFICAS (2015)
Update on Hidradenitis Suppurative (Part II): treatment
A. Martorell et al.
ACTAS DERMO-SIFILIOGRAFICAS (2015)
Hidradenitis suppurativa: the role of immune dysregulation
Genevieve Kelly et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Charles W. Lynde et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
Daniel A. Gold et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity
Anne M. R. Schrader et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial
Alexa B. Kimball et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments
Hessel H. van der Zee et al.
EXPERIMENTAL DERMATOLOGY (2012)
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
Kyung-Ah Cho et al.
INTERNATIONAL IMMUNOLOGY (2012)
Hidradenitis Suppurativa
Gregor B. E. Jemec
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Christoph Schlapbach et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?
Z. Rezaieyazdi et al.
LUPUS (2011)
Increased Serum Tumour Necrosis Factor-alpha in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-alpha Agents?
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging
Lukasz Matusiak et al.
BIOMARKERS (2009)
Hidradenitis suppurativa
J. Revuz
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
E. J. Giamarellos-Bourboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Share Paper
